MX9710206A - Composicion farmaceutica de amiodarone para administracion parenteral. - Google Patents

Composicion farmaceutica de amiodarone para administracion parenteral.

Info

Publication number
MX9710206A
MX9710206A MX9710206A MX9710206A MX9710206A MX 9710206 A MX9710206 A MX 9710206A MX 9710206 A MX9710206 A MX 9710206A MX 9710206 A MX9710206 A MX 9710206A MX 9710206 A MX9710206 A MX 9710206A
Authority
MX
Mexico
Prior art keywords
composition
amiodarone
parenteral delivery
pharmaceutical
active principle
Prior art date
Application number
MX9710206A
Other languages
English (en)
Inventor
Jean-Claude Gautier
Regine Bellamy
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX9710206A publication Critical patent/MX9710206A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Abstract

La invencion tiene por objeto una composicion farmacéutica para administracion parenteral, caracterizada en que comprende: de 1.5 a 8% en peso de un principio activo constituido por el amiodarone o una de sus sales farmacéuticamente aceptable; una solucion amortiguadora fisiologicamente aceptable, capaz de solubilizar el principio activo y mantener el pH de la composicion entre 2.4 y 3.8; una agente tensioactivo hidrofilo no ionico.
MX9710206A 1995-06-30 1996-06-28 Composicion farmaceutica de amiodarone para administracion parenteral. MX9710206A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9507939A FR2735978B1 (fr) 1995-06-30 1995-06-30 Composition pharmaceutique d'amiodarone pour administration parenterale
PCT/FR1996/001010 WO1997002031A1 (fr) 1995-06-30 1996-06-28 Composition pharmaceutique d'amiodarone pour administration parenterale

Publications (1)

Publication Number Publication Date
MX9710206A true MX9710206A (es) 1998-03-31

Family

ID=9480596

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9710206A MX9710206A (es) 1995-06-30 1996-06-28 Composicion farmaceutica de amiodarone para administracion parenteral.

Country Status (14)

Country Link
US (1) US6143778A (es)
EP (1) EP0835105B1 (es)
JP (1) JP3137987B2 (es)
AT (1) ATE213940T1 (es)
AU (1) AU6462596A (es)
BR (1) BR9609666A (es)
CA (1) CA2222304C (es)
DE (1) DE69619673T2 (es)
ES (1) ES2174083T3 (es)
FR (1) FR2735978B1 (es)
MX (1) MX9710206A (es)
NO (1) NO317061B1 (es)
WO (1) WO1997002031A1 (es)
ZA (1) ZA965525B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7339078B2 (en) * 1995-03-10 2008-03-04 G.D. Searle Llc Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6861539B1 (en) 1995-03-10 2005-03-01 G. D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
FR2764800B1 (fr) * 1997-06-23 1999-09-10 Sanofi Sa Composition pharmaceutique solide contenant des derives de benzofuranne
US6479541B1 (en) 2000-03-30 2002-11-12 Baxter International Amiodarone-containing parenteral administration
US6646195B1 (en) * 2000-04-12 2003-11-11 Microsoft Corporation Kernel-mode audio processing modules
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
JP2004528315A (ja) * 2001-03-29 2004-09-16 バクスター・インターナショナル・インコーポレイテッド 予備混合アミオダロンの非経口溶液および同溶液を作製するための方法
US20020143051A1 (en) 2001-03-29 2002-10-03 Doty Mark J. Premixed amiodarone parenteral solution and method for making the same
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
WO2003000158A1 (en) * 2001-06-22 2003-01-03 Bentley Pharmaceuticals, Inc. Pharmaceutical composition
CA2461349C (en) 2001-09-26 2011-11-29 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US6869939B2 (en) 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
PT2279729T (pt) * 2003-07-17 2016-09-22 Banner Life Sciences Llc Preparações de libertação controlada
CA2536283A1 (en) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Pharmaceutical preparations having an improved solubility
MY148255A (en) 2004-04-26 2013-03-29 Mitsubishi Materials Corp Reducing water purification material, method for producing reducing water purification material, method for treating wastewater, and wastewater treatment apparatus
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
CN102316952B (zh) * 2009-02-16 2016-06-22 株式会社可乐丽 过滤单元以及具备该过滤单元的压载水制造装置
EP2335686A1 (en) 2009-12-21 2011-06-22 LEK Pharmaceuticals d.d. An aqueous intravenous nanosuspension with reduced adverse effects
EP2579869A2 (en) 2010-06-11 2013-04-17 Baxter International Inc Formulations including amiodarone and salts thereof and methods of their manufacture and use
EP3150559A4 (en) * 2014-05-28 2018-02-21 Takeda Pharmaceutical Company Limited Antibacterial water
WO2018175271A1 (en) * 2017-03-24 2018-09-27 Merck Sharp & Dohme Corp. Formulation for parenteral administration
US20220016070A1 (en) * 2020-07-17 2022-01-20 Good Health, Llc Premixed, ready to use pharmaceutical compositions of amiodarone
CN112472668B (zh) * 2020-10-29 2023-02-28 太阳升(亳州)生物医药科技有限公司 用于制备盐酸胺碘酮注射液的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234949A (en) * 1992-04-01 1993-08-10 Academic Pharmaceuticals, Inc. Parenteral solutions containing amiodarone in acetate buffer solution

Also Published As

Publication number Publication date
FR2735978A1 (fr) 1997-01-03
FR2735978B1 (fr) 1997-09-19
EP0835105A1 (fr) 1998-04-15
BR9609666A (pt) 1999-05-25
CA2222304A1 (fr) 1997-01-23
ZA965525B (en) 1997-12-29
WO1997002031A1 (fr) 1997-01-23
NO317061B1 (no) 2004-08-02
NO976125L (no) 1998-02-26
ES2174083T3 (es) 2002-11-01
NO976125D0 (no) 1997-12-29
US6143778A (en) 2000-11-07
ATE213940T1 (de) 2002-03-15
JPH10510297A (ja) 1998-10-06
EP0835105B1 (fr) 2002-03-06
AU6462596A (en) 1997-02-05
CA2222304C (fr) 2002-09-17
JP3137987B2 (ja) 2001-02-26
DE69619673T2 (de) 2002-11-14
DE69619673D1 (de) 2002-04-11

Similar Documents

Publication Publication Date Title
MX9710206A (es) Composicion farmaceutica de amiodarone para administracion parenteral.
MY122124A (en) Solid pharmaceutical composition containing benzofurane derivatives
AU692430C (en) Aqueous pharmaceutical preparations of G-CSF with a long shelf life
DK0858328T3 (da) Stabile præparater indeholdende N-propargyl-1-aminoindan
CA2338358A1 (en) Compounds and compositions for delivering active agents
HRP20020929A2 (en) Sustained release pharmaceutical cmpositions for parenteral administration of hydrophilic compounds
CA2339765A1 (en) Compounds and compositions for delivering active agents
CA2282345A1 (en) Pharmaceutical composition
CA2326222A1 (en) Medicinal compositions
CA2226548A1 (en) Lyophilized hepatocyte growth factor preparations
TW327602B (en) A pharmaceutical composition of an ophthalmic suspension containing difluprednate
YU46503A (sh) Farmaceutski oblik dronedarona za parenteralnu upotrebu
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
EE03224B1 (et) Prolongeeritud toimega süstesuspensioonid ja nende valmistamismeetod
BR9809708A (pt) Composições farmacêuticas de peptìdeos tendo solubilidade baixa em meio fisiológico
PT1187611E (pt) Composicoes oftalmicas de histamina e sua utilizacoes
AU620218B2 (en) Anti-hiv drug
IE890275L (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
AU7533394A (en) Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel
CA2130988A1 (en) Pharmaceutical Composition for Treatment of Sudden Deafness
CA2373166A1 (en) Antiulcer agent
EP1676832A3 (en) Compounds and compositions for delivering active agents
MX9605633A (es) Composicion farmaceutica, metodo y dispositivo para prevenir o tratar resequedad de los ojos o enfermedad ocasionada por la misma.